SCHEMBL25099321

SCHEMBL25099321

CCC(CCCN)NC(=O)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 7/20 0.40
DPP8 Q6V1X1 6/20 0.40
DPP9 Q86TI2 5/20 0.40
DPP4 P27487 2/20 0.40
GNAI3 P08754 1/20 0.35
GNAO1 P09471 1/20 0.35
GNAI1 P63096 1/20 0.35
SIRT6 Q8N6T7 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
RRM1 P23921 1/20 0.33
CA12 O43570 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP8 P22894 1/20 0.33
CA9 Q16790 1/20 0.33
SLC15A1 P46059 1/20 0.33
GABRR1 P24046 2/20 0.32
CPB2 Q96IY4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15468315 0.83 DPP8 (0.36) DPP7DPP8DPP9DPP4GNAI3
SCHEMBL13072059 0.81 PLA2G2C (0.44) DPP7DPP8DPP9DPP4SIRT6
SCHEMBL20146285 0.80 TAS1R3 (0.44) CA1CA2CA12MMP1MMP2
SCHEMBL2779977 0.80 NMT2 (0.40) DPP7DPP8DPP9DPP4GNAI3
SCHEMBL8899976 0.80 MMP1 (0.48) CA1CA2CA12MMP1MMP2
SCHEMBL19091233 0.78 DPP7 (0.58) DPP7DPP8DPP9DPP4GNAI3
SCHEMBL25543957 0.76 KDM4E (0.47) DPP7GNAI3GNAO1GNAI1SIRT6
SCHEMBL25099141 0.76 DPP7 (0.37) DPP7DPP8DPP9DPP4GNAI3
SCHEMBL15846224 0.75 TSHR (0.42) DPP7DPP8DPP9DPP4GNAI3
SCHEMBL25099320 0.74 MMP1 (0.41) CA1CA2CA12MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230077316-A1 CTPS1 INHIBITORS AND USES THEREOF NIMBUS DISCOVERY, INC. 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230077316-A1 CTPS1 INHIBITORS AND USES THEREOF CTPS1, CTPS2, ECHS1 DPP7 1776/4885DPP8 1810/4885DPP9 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.